The FDA has reversed its earlier decision to require employees to return to the office, citing concerns over recent layoffs and resignations that threaten essential operations like drug approvals. Internal communications indicate that review staff and supervisors can now telework at least twice a week. This policy change occurred following significant workforce reductions—over 15%—which affected key areas including drug regulation and communication teams. Former officials have criticized the chaotic restructuring process as detrimental to the agency's functioning.
"Staffers have described lower level employees as 'pouring' out of the agency."
"Former FDA Commissioner Dr. David Kessler called the cuts 'devastating, haphazard, thoughtless and chaotic' during a House hearing on Wednesday."
Collection
[
|
...
]